| Literature DB >> 34485580 |
Devon E Anderson1,2, Eric A Bogner3, Scott R Schiffman4, Scott A Rodeo5, Jack Wiedrick6, Dennis C Crawford1.
Abstract
BACKGROUND: Studies have reported favorable clinical outcomes after osteochondral allograft (OCA) transplantation to treat osteochondral defects and have demonstrated that healing of the osseous component may be critical to outcomes. However, there is currently no consensus on the optimal modality to evaluate osseous healing.Entities:
Keywords: computed tomography; osseous integration; osteochondral allograft transplantation; patient-reported outcomes; radiographic outcomes
Year: 2021 PMID: 34485580 PMCID: PMC8414629 DOI: 10.1177/23259671211022682
Source DB: PubMed Journal: Orthop J Sports Med ISSN: 2325-9671
Figure 1.Representation of computed tomography (CT) scoring parameters used to characterize osseous healing after osteochondral allograft (OCA) transplantation. (A) Coronal, sagittal, and axial CT scans from a patient after OCA transplantation were used to develop (B) schematics for standardization of CT evaluation for the following parameters: bone incorporation, bone density, surface congruency, cystic changes, and sclerosis. HU, Hounsfield units.
Surgical and Characteristic Variables for Patients Included in the Final Analysis and for Patients Considered Lost to Follow-up
| Variable | Final Cohort (N = 60) | Lost to Follow-up (n = 58) |
|
|---|---|---|---|
| Age at surgery, y | 39.58 ± 15.06 (15-69) | 33.90 ± 13.24 (15-68) |
|
| Graft donor age, y | 23.82 ± 6.40 (13-39) | 21.73 ± 4.43 (12-280) | .25 |
| Weight at surgery, kg | 84.29 ± 14.82 (50-113) | 86.76 ± 19.28 (53-146) | .43 |
| BMI at surgery | 27.38 ± 4.85 (19-38) | 28.14 ± 4.57 (20-42) | .38 |
| Female sex, n (%) | 16 (27) | 24 (41) | NA |
| Hispanic, n (%) | 3 (5) | 2 (3) | NA |
| Prior surgery, n (%) | 49 (82) | 47 (81) | NA |
| No. of prior surgeries | 0.93 ± 0.71 (0-5) | 1.09 ± 0.81 (0-4) | NA |
| Size of lesion, cm2 | 5.13 ± 2.33 (1.50-12.50) | 5.60 ± 2.89 (0.25-16.00) | .43 |
| Side affected, left/right, n | 30/30 | 32/26 | NA |
| Multiple grafts, n (%) | 13 (22) | 17 (29) | NA |
| Revision surgery, n (%) | 16 (27) | 4 (7) | NA |
| Graft failure, n (%) | 2 (3) | 0 (0) | NA |
Data are reported as mean ± SD (range) unless otherwise indicated. Bolded P value indicates a statistically significant difference between groups (P < .05). BMI, body mass index; NA, not applicable.
Patients who underwent osteochondral allograft transplantation during the study period but did not have computed tomography scans or complete patient-reported outcomes postoperatively.
n = 15 patients.
n = 58 patients.
Concomitant Procedures Performed With Osteochondral Allograft Transplantation
| Concomitant Procedure | No. |
|---|---|
| High tibial osteotomy | 3 |
| Tibial tubercle osteotomy | 3 |
| Loose body removal | 13 |
| ACL reconstruction | 7 |
| MPFL reconstruction | 1 |
| Arthroscopic meniscectomy | 5 |
| Arthroscopic lateral release | 4 |
| Meniscal allograft transplantation | 5 |
ACL, anterior cruciate ligament; MPFL, medial patellofemoral condyle.
Reoperations After Index Osteochondral Allograft Transplantation Surgery
| Procedure | No. |
|---|---|
| Arthroscopic meniscectomy | 1 |
| Arthroscopic chondroplasty/loose body removal/removal of hardware | 9 |
| ACL reconstruction | 2 |
| High tibial osteotomy | 1 |
| Femoral realignment osteotomy | 1 |
| Autologous chondrocyte implantation | 1 |
| Total knee arthroplasty | 1 |
ACL, anterior cruciate ligament.
Represents clinical failure of treatment based on revision of osteochondral allograft.
Cartilage Lesion Characteristics: Mechanism of Osteochondral Injury, Lesion Location, and Number of Grafts Used (N = 60 Patients, 73 Grafts)
| Mechanism of Injury | Lesion Location | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| LFC | MFC | LFC+MFC | Trochlea | Patella | ||||||
| 1 Graft | 2 Grafts | 1 Graft | 2 Grafts | 1 Graft | 2 Grafts | 1 Graft | 2 Grafts | 1 Graft | 2 Grafts | |
| Osteochondritis dissecans | 15 | 2 | 11 | 3 | — | — | — | — | — | — |
| Traumatic chondral injury | 4 | — | 4 | 2 | — | 2 | 2 | — | 1 | — |
| Degenerative chondral lesion | 2 | — | 4 | 3 | — | 1 | — | — | — | — |
| Avascular necrosis | 1 | — | 2 | — | — | — | — | — | — | — |
| Patellar instability | — | — | — | — | — | — | 1 | — | — | — |
Dashes indicate no data. LFC, lateral femoral condyle; MFC, medial femoral condyle.
Summary of Inter- and Intrarater Reliability
| CT Parameter | Interrater ICC (95% CI) | Intrarater ICC (95% CI) |
|---|---|---|
| Bone incorporation | 0.78 (0.58 to 0.89) | 0.73 (0.30 to 0.89) |
| Surface congruency | 0.39 (0.03 to 0.66) | 0.88 (0.73 to 0.95) |
| Host bone density | 0.29 (0.00 to 0.62) | 0.64 (0.18 to 0.88) |
| Graft bone density | 0.44 (0.09 to 0.69) | 0.73 (0.30 to 0.89) |
| Cystic change | 0.56 (0.25 to 0.77) | 0.87 (0.74 to 0.94) |
| Sclerosis | –0.46 (–0.72 to –0.05) | 0.84 (0.69 to 0.92) |
Reliability was calculated using intraclass correlation coefficients (ICCs) assessed via an analysis of variance estimator of a 2-way random-effects model of absolute agreement. CT, computed tomography.
Figure 2.(A) Theoretical expected and observed distribution of composite computed tomography (CT) score parameters based on the modeling of Mahalanobis distances with chi-square distribution. (B) Observed variance (mean ± SD) of individual Mahalanobis distance for individual CT scans relative to the cohort.
Summary of CT Parameters (N = 60 Patients, 73 Scans)
| CT Parameter | Mean ± SD (range) | Interpretation |
|---|---|---|
| Bone incorporation, % | 2.92 ± 1.05 (0.00 to 4.00) | On average, cohort had approximately 50%-75% graft incorporation |
| Host bone density, HU | 257.28 ± 74.07 (132.80 to 497.00) | Average of 5 density measurements |
| Graft bone density, HU | 549.53 ± 130.61 (119.00 to 926.00) | Average of 5 density measurements |
| Surface congruency, mm | –0.22 ± 1.22 (–4.10 to 3.90) | Average 0.22-mm depression of graft relative to host |
| Cystic change | 1.79 ± 1.10 (0.00 to 3.00) | Average largest cyst measured <1 mm |
CT, computed tomography; HU, Hounsfield units.
Change in PRO From Baseline to Final Follow-up
| PRO | Patients, n | Baseline | Final Follow-up | Change |
| Effect Size |
|---|---|---|---|---|---|---|
| IKDC | 58 | 41.70 ± 16.01 | 64.13 ± 21.60 | 22.58 ± 22.53 |
| 1.41 |
| KOOS ADL | 56 | 72.28 ± 18.76 | 84.03 ± 20.73 | 12.63 ± 20.86 |
| 0.67 |
| KOOS Pain | 56 | 66.42 ± 16.48 | 76.49 ± 21.29 | 10.57 ± 22.46 |
| 0.64 |
| KOOS QOL | 56 | 24.40 ± 16.36 | 48.42 ± 24.59 | 23.31 ± 24.60 |
| 1.43 |
| KOOS Sport | 52 | 37.10 ± 23.04 | 60.00 ± 29.83 | 24.73 ± 29.12 |
| 1.07 |
| KOOS Symptoms | 56 | 64.01 ± 16.54 | 71.66 ± 21.91 | 7.66 ± 23.67 |
| 0.46 |
| VR-12 mental | 18 | 50.88 ± 13.53 | 52.40 ± 10.80 | 2.51 ± 17.35 | .514 | –0.19 |
| VR-12 physical | 18 | 37.16 ± 10.23 | 45.19 ± 11.02 | 10.43 ± 11.41 |
| 1.02 |
The number of patients is less than the total cohort (N = 60) because at least 1, but not all, patient-reported outcomes (PROs) may have been completed by an individual at baseline and follow-up. ADL, Activities of Daily Living; IKDC, International Knee Documentation Committee; KOOS, Knee injury and Osteoarthritis Outcome Score; QOL, Quality of Life; VR-12, Veterans RAND 12-Item Health Survey.
Bolded P values indicate a statistically significant difference between groups (P < .05).
Partial Correlation From Structural Equation Modeling at Final Follow-up
| PRO | Bone Incorporation | Surface Congruency | Host Bone Density | Graft Bone Density | Cystic Change |
|---|---|---|---|---|---|
| IKDC | 0.025 (.851) | 0.055 (.678) | 0.066 (.617) | –0.034 (.797) | –0.036 (.786) |
| KOOS ADL | –0.151 (.278) | 0.009 (.951) | 0.132 (.345) | 0.064 (.649) | 0.019 (.891) |
| KOOS Pain | 0.042 (.765) | –0.031 (.827) | 0.133 (.339) | –0.009 (.950) | –0.011 (.936) |
| KOOS QOL | 0.022 (.878) | 0.126 (.367) | 0.208 (.133) | 0.079 (.575) | –0.040 (.775) |
| KOOS Sports and Recreation | –0.030 (.846) | –0.006 (.970) | 0.108 (.477) | –0.041 (.790) | 0.063 (.682) |
| KOOS Symptoms | –0.006 (.965) | –0.050 (.723) | 0.134 (.336) | –0.069 (.621) | –0.105 (.453) |
| VR-12 mental | 0.136 (.765) | –0.100 (.827) | 0.044 (.923) | 0.294 (.508) | 0.001 (.998) |
| VR-12 physical | 0.043 (.925) | 0.264 (.555) | 0.006 (.989) | –0.015 (.973) | 0.085 (.853) |
values are given in parentheses. ADL, Activities of Daily Living; IKDC, International Knee Documentation Committee; KOOS, Knee injury and Osteoarthritis Outcome Score; PRO, patient-reported outcome; QOL, Quality of Life; VR-12, Veterans RAND 12-Item Health Survey.